ImageneBio (IMA) Amortizatization of Intangibles (2023 - 2025)
ImageneBio (IMA) posted Amortizatization of Intangibles of -$210000.0 for Q3 2025, down 186.42% sequentially from $243000.0 in Q2 2025, and up 74.3% YoY from -$120484.6 in Q3 2024.
ImageneBio (IMA) Amortizatization of Intangibles (2023 - 2025) Analysis & Trends
ImageneBio has reported Amortizatization of Intangibles for 3 years, with the latest figure at -$210000.0 in Q3 2025.
- Quarterly Amortizatization of Intangibles rose 74.3% year-over-year to -$210000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.5 million (up 378.03% YoY) and the FY2024 annual result came in at $1.5 million, down 27.43% from the prior year.
- Amortizatization of Intangibles declined to -$210000.0 in Q3 2025 per IMA's latest filing, from $243000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.5 million in Q4 2024 and troughed at -$817000.0 in Q3 2024.
- A 3-year average of $352400.0 and a median of $408500.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- The widest YoY moves for Amortizatization of Intangibles: up 367.52% in 2024, down 241.59% in 2024.
- Over 3 years, Amortizatization of Intangibles stood at $314000.0 in 2023, then surged by 367.52% to $1.5 million in 2024, then plunged by 114.31% to -$210000.0 in 2025.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$210000.0, $243000.0, and $1.5 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -210,000.00 |
| Sep 30, 2025 | -210,000.00 |
| Jun 30, 2025 | 243,000.00 |
| Jun 30, 2025 | 243,000.00 |
| Dec 31, 2024 | 1.47 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | -817,000.00 |
| Sep 30, 2024 | -817,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Mar 31, 2024 | 393,000.00 |
| Mar 31, 2024 | 393,000.00 |
| Dec 31, 2023 | 314,000.00 |
| Dec 31, 2023 | 314,000.00 |
| Sep 30, 2023 | 577,000.00 |
| Sep 30, 2023 | 577,000.00 |
| Jun 30, 2023 | 602,000.00 |
| Jun 30, 2023 | 602,000.00 |
| Mar 31, 2023 | 530,000.00 |
| Mar 31, 2023 | 530,000.00 |